Publishing research using ab72069? Please let us know so that we can cite the reference in this datasheet.

ab72069 has been referenced in 4 publications.

  • Dine JL  et al. The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl. Breast Cancer Res Treat 155:235-51 (2016). IHC ; Human . PubMed: 26759246
  • Hsieh MS  et al. The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma. Oncotarget 7:36956-36970 (2016). WB, IHC . PubMed: 27172793
  • Qu XH  et al. Insights into the roles of hnRNP A2/B1 and AXL in non-small cell lung cancer. Oncol Lett 10:1677-1685 (2015). PubMed: 26622731
  • Leconet W  et al. Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy. Oncogene N/A:N/A (2013). PubMed: 24240689

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up